Concepedia
Statistics
Publications
16
Citations
1.5K
H-Index
13
Active since
1954
Affiliations
University of Chicago(Current)
Northern Indiana Cancer Research Consortium
Hematology Oncology Associates
Cancer Care Specialists of Illinois
Hoosier Cancer Research Network (United States)
David Taber is an author at University of Chicago specializing in medicine, oncology, and radiation oncology.
Top concepts
MedicineOncologyRadiation OncologyCancer TherapyCancer ResearchPathologyLung CancerPharmacologyPharmacotherapyDermatology
Publications per year
1954–2012
Phase II Trial of Bevacizumab Plus Gemcitabine in Patients With Advanced Pancreatic Cancer
Hedy L. Kindler, Gregory Friberg, D. A. Singh et al. · Journal of Clinical Oncology · 2005 · 458 citations · Full text
Multicenter, Double-Blind, Placebo-Controlled, Randomized Phase II Trial of Gemcitabine/Cisplatin Plus Bevacizumab or Placebo in Patients With Malignant Mesothelioma
Hedy L. Kindler, Theodore Karrison, David R. Gandara et al. · Journal of Clinical Oncology · 2012 · 256 citations · Full text
Flavopiridol, A Novel Cyclin-Dependent Kinase Inhibitor, in Metastatic Renal Cancer: A University of Chicago Phase II Consortium Study
Walter M. Stadler, Nicholas J. Vogelzang, Robert J. Amato et al. · Journal of Clinical Oncology · 2000 · 208 citations
Phase II Trial of Weekly Intravenous Gemcitabine With Continuous Infusion Fluorouracil in Patients With Metastatic Renal Cell Cancer
Brian I. Rini, Nicholas J. Vogelzang, M Dumas et al. · Journal of Clinical Oncology · 2000 · 155 citations
Phase II Trial of PS-341 in Patients With Renal Cell Cancer: A University of Chicago Phase II Consortium Study
Nancy B. Davis, David Taber, Rafat Ansari et al. · Journal of Clinical Oncology · 2003 · 141 citations · Full text
1–5 of 16